JoMO-UKCPA Medicines Optimisation Meeting (Cardiovascular)

"Our staff got such a lot out of your last event and showcasing their work. The whole thing was a feel good vibe for everyone."
Julia Simms, Head of Medicines Management, North West Commissioning Support Unit
Event Name JoMO-UKCPA Medicines Optimisation Meeting (Cardiovascular)
Location Leicester Marriott Hotel, Leicester
Start Date 9:30am 19/09/2017
Finish Date 4:00pm 19/09/2017
Booking Closes 5:00pm 14/09/2017
Places Available
Event Description

Our first joint workshop on best practice in the use of medicines in cardiovascular conditions.

The satellites confirmed are:

Managing Cardiovascular related co-morbidities in patients with type 2 diabetes: Adopting a multi-factorial approach - Michelle Lam, Specialist Diabetes Pharmacist, St James' Hospital, Leeds - Novo Nordisk has organised and fully funded this symposium

Ischaemic Heart Disease - Danny Forrest, Deputy Chief and Cardiology Pharmacist, Liverpool Heart and Chest Hospital NHS Foundation Trust

Heart Failure - Nazish Khan, Cardiac Pharmacist, Royal Wolverhampton NHS Trust

Acute Stroke Management (inc thrombolysis) - Kuldeep Paik, Non Medical Prescriber, Neurosciences Division, St George's University Hospitals NHS Foundation Trust

Aphasia and Dysphagia post-stroke - Paresh Parmar, Lead Pharmacist for Stroke and Care of the Elderly, Northwick Park Hospital/London North West Healthcare NHS Trust 

The Role of the GP Clinical Pharmacist in CV Disease - Rena Amin, Clinical Associate, Hartland Way Surgery, London

Vascular Risk Assessment and primary prevention - Michaela Nuttall, Cardiovascular Nurse Specialist, Smart Health Solutions

Innovation to prevent AF-related stroke - the role of the AHSNs - Laura Spratling, Programme Manager, Health Innovation Network, South London and Helen Williams, Consultant Pharmacist for Cardiovascular Disease, South London, Clinical Director for Atrial Fibrillation, Health Innovation Network, Clinical Associate for CV Disease, Southwark CCG, Clinical Network Lead for CV Disease, Lambeth CCG

Atrial Fibrillation - Dr Matthew Fay, GP, The Willows Medical Practice , Bradford

Innovative approaches to improve medicines optimisation in CHD - Dr Rani Khatib, Consultant Pharmacist in Cardiology and Cardiovascular Clinical Research, Leeds Teaching Hospitals NHS Trust and University of Leeds

Antithrombotics - managing combination therapies - Paul Wright, Lead Cardiac Pharmacist, Barts Health NHS Trust

Evidence for and practical use of DOACS - Rebecca Chanda, Highly Specialist Pharmacist Anticoagulation, Guy’s and St Thomas Hospital,  & Honorary Clinical Lecturer, King’s College London and Rosalind Byrne, Senior Anticoagulation and Clinical Thrombosis Pharmacist, King's College Hospital NHS Foundation Trust

Delivering Excellence in Anticoagulant Care - Helen Williams, Consultant Pharmacist for Cardiovascular Disease, South London, Clinical Director for Atrial Fibrillation, Health Innovation Network, Clinical Associate for CV Disease, Southwark CCG, Clinical Network Lead for CV Disease, Lambeth CCG

Hypertension - Imran Hafiz, Cardiovascular Pharmacist, Guy's and St Thomas' NHS Foundation Trust

Specialist Management of Heart Failure - Alison Warren, Consultant Pharmacist Cardiology, Brighton and Sussex University Hospitals NHS Trust and Brighton and Hove CCG

Acute Coronary Syndromes - Steve McGlynn, Specialist Principal Pharmacist (Cardiology), NHS Greater Glasgow and Clyde

Understanding Coronary Interventions (inc TAVI) - Dr Michael Norell, Consultant Cardiologist & Clinical Director, Cardiothoracic Services, Heart & Lung Centre – The Royal Wolverhampton Hospitals NHS Trust

Anticoagulation for DVT and PE - Katherine Stirling, Consultant Pharmacist - Anticoagulation and Thrombosis, Leeds Teaching Hospitals NHS Trust

This event will be funded by the following pharmaceutical companies through the purchase of event sponsorship, sponsored satellites, exhibition stands and posters. These companies have had no input into the design or content of the workshop agenda (with the exception of sponsored satellites) but will be in attendance on the day.

Headline Sponsor - Daiichi Sankyo

Satellite Sponsor - Novo Nordisk

Stand Sponsors - Alliance Pharmaceuticals, Aspire Pharma, Novartis, Thornton and Ross

The Learning Zone, which is made up of Posters and Exhibition Stands, is a gathering place and central point for exchange of best practice. To submit your work on Medicines Optimisation in Cardiovascular download the poster submission form here.

Pharmacy Management will reimburse standard class travel and any appropriate mileage associated with your attendance at this meeting. A claim form will be sent to you along with the joining instructions for you to submit after the event along with the original receipts.

 

Agenda Download Agenda PDF
Contact Name Alistair Paul
More Details Email for more details.
Your booking is always provisional until we confirm it!
Login Register

Satellites for this Event

Acute Coronary Syndromes

Speakers: Steve McGlynn, Specialist Principal Pharmacist (Cardiology), NHS Greater Glasgow and Clyde

Pharmacological Management of Acute Coronary Syndromes

Coronary Heart Disease (CHD) remains the most common cause of death in the Western World and is a...

Read more »

Heart Failure

Speakers: Nazish Khan, FFRPS, MPharmS, DPharm, IPresc, Clin Dip Pharm, Principal Pharmacist Cardiac Services, The Royal Wolverhampton Hospitals NHS Trust

Up to 2% of the adult population are affected by heart failure (HF), and its prevalence is likely to increase further due to improved survival following a myocardial infarction ...

Read more »

Atrial Fibrillation

Speakers: Dr Matthew Fay, GP, The Willows Medical Practice, Bradford

The issues around stroke prevention in AF were established with the publication of the SPAF1 study in the early nineties. However despite two iterations of the national guidelin...

Read more »

Antithrombotics - managing combination therapies

Speakers: Paul Wright, Lead Cardiac Pharmacist, Barts Health NHS Trust

This session will focus on a common conundrum occurring in patients undergoing angioplasty – it is estimated that 10% of patients undergoing PCI will have an indication fo...

Read more »

Vascular Risk Assessment and primary prevention

Speakers: Michaela Nuttall, Cardiovascular Nurse Specialist, Smart Health Solutions

Do you really know how to explain cardiovascular risk?

Vascular risk assessment is so much more than using a CVD risk calculator.  In this interactive session we wi...

Read more »

Understanding Coronary Interventions (inc TAVI)

Speakers: Dr Michael Norell, Consultant Cardiologist & Clinical Director, Cardiothoracic Services, Heart & Lung Centre – The Royal Wolverhampton Hospitals NHS Trust

Read more »

Managing cardiovascular related co-morbidities in patients with type 2 diabetes: adopting a multi-factorial approach

Speakers: Michelle Lam, Specialist Diabetes Pharmacist, St James' Hospital, Leeds

This session will focus on how adopting a multi-factorial approach to management of people with type 2 diabetes can improve patient cardiovascular outcomes through lifestyle mod...

Read more »

Innovation to prevent AF-related stroke - the role of the AHSNs

Speakers: Laura Spratling (Programme Manager, Health Innovation Network, South London) and Helen Williams (Consultant Pharmacist for Cardiovascular Disease, South London; Clinical Director for Atrial Fibrillation, Health Innovation Network; Clinical Associate for CV Disease, Southwark CCG; Clinical Network Lead for CV Disease, Lambeth CCG)

Read more »

Anticoagulation for DVT and PE

Speakers: Katherine Stirling, Consultant Pharmacist - Anticoagulation and Thrombosis, Leeds Teaching Hospitals NHS Trust

This session will use case studies to explore different treatment options for patients who have had a DVT or PE. It will include newly diagnosed patients as well as those requir...

Read more »

The Role of the GP Clinical Pharmacist in CV Disease

Speakers: Rena Amin, Clinical Associate, Hartland Way Surgery, London

GP practice based pharmacists are ideally positioned to support the national drivers around Rightcare to maximize improvement opportunities in CVD areas. This satellite session ...

Read more »

Innovative approaches to improve medicines optimisation in CHD

Speakers: Dr Rani Khatib, Consultant Pharmacist in Cardiology and Cardiovascular Clinical Research. Leeds Teaching Hospitals NHS Trust and University of Leeds

Innovative approaches to improve medicines optimisation in CHD

National and international evidence based guidelines make recommendation on how to reduce...

Read more »

Specialist Management of Heart Failure

Speakers: Alison Warren, Consultant, Consultant Pharmacist Cardiology, Brighton and Sussex University Hospitals NHS Trust and Brighton and Hove CCG

Specialist Management of Heart Failure

Heart failure is a complex syndrome and the evidence base for the initial pharmacological treatment is well established.  Pha...

Read more »

Evidence for and Practical use of DOACS

Speakers: Rebecca Chanda (Highly Specialist Pharmacist Anticoagulation, Guy’s and St Thomas Hospital & Honorary Clinical Lecturer, King’s College London.) and Rosalind Byrne (Senior Anticoagulation and Clinical Thrombosis Pharmacist, King's College Hospital NHS Foundation Trust)

Which DOAC for which patient? There are now four direct oral anticoagulants (DOACs) available for the prevention of AF-related stroke and for the treatment of VTE. This satellit...

Read more »

Aphasia and Dysphagia post-stroke

Speakers: Paresh Parmar, Lead Pharmacist for Stroke and Care of the Elderly, Northwick Park Hospital/London North West Healthcare NHS Trust

Aphasia and Dysphagia are both common consequences post-stroke. Pharmacists work closely with speech and language therapists who assess patients with aphasia and dysphagia. Arou...

Read more »

Ischaemic Heart Disease

Speakers: Danny Forrest, Deputy Chief and Cardiology Pharmacist, Liverpool Heart and Chest Hospital NHS Foundation Trust

Where are we in 2017? Opportunities for medicines optimisation and risk factor modification have never been higher for pharmacists, especially for those working in primary care....

Read more »

Hypertension

Speakers: Imran Hafiz, Cardiovascular Pharmacist, Guy's and St Thomas' NHS Foundation Trust, and team

Hypertension is a common condition and a precursor to many others.  Many regard it as “simple” to manage disease.  Despite this, and the plethora of treatm...

Read more »

Acute Stroke Management (inc thrombolysis)

Speakers: Kuldeep Paik, Non Medical Prescriber, Neurosciences Division, St George's University Hospitals NHS Foundation Trust

The treatment of patients with acute stroke and their subsequent recovery depends greatly on making the right decisions within the acute setting.

Find out more abou...

Read more »

Delivering excellence in anticoagulant care

Speakers: Helen Williams, Consultant Pharmacist for Cardiovascular Disease, South London; Clinical Director for Atrial Fibrillation, Health Innovation Network; Clinical Associate for CV Disease, Southwark CCG; Clinical Network Lead for CV Disease, Lambeth CCG

Read more »

Connect with us Industry NHS

Confirmation

This site is intended for healthcare professionals or people employed in the pharmaceutical industry. Please confirm that you are such a person.

Continue